FluimediX
FluimediX (Point of Cow) is a Danish diagnostics company that sells an on-farm BACT test and Mini-Incubator to dairy farmers for rapid identification of mastitis-causing bacteria, enabling reduced antibiotic use and regulatory compliance.
- Company typePrivate
- Founded2017
- HeadquartersTaastrup, Denmark
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What FluimediX does
FluimediX ApS, operating commercially under the Point of Cow brand, is a Danish private limited company (CVR 27021689) headquartered at Naverland 7-9, Glostrup, Denmark. Its sole commercial focus is on-farm bacterial diagnostics for mastitis in dairy cattle, sold direct to farmers through its e-commerce site pointofcow.dk.
The company's core offering is the BACT test, a culture-based on-farm assay that distinguishes Gram-negative mastitis pathogens (E. coli and Klebsiella) from Gram-positive and other causes within a single workday. The test is paired with a proprietary Mini-Incubator required to process samples on-site. Together, the system allows farmers to identify mastitis cases that do not require antibiotic treatment, instead managing them with pain relief alone. The product is positioned against a Danish regulatory backdrop (effective June 1, 2020) that mandates veterinary testing before acute antibiotic treatments, which the company leverages in its messaging to amplify the cost-saving case.
Commercially, FluimediX runs a direct-to-consumer model with low-priced hardware and consumables: a Starter-Kit at 990 DKK, a 10-unit refill pack at 570 DKK, and the Mini-Incubator at 695 DKK, all on a pay-as-you-go basis. Its customers are Danish dairy farmers, with livestock veterinarians as a secondary beneficiary. The firm reports 11–50 employees, has no disclosed funding, no institutional investors, and no partnerships. Leadership consists of CEO Tomas Ussing; no broader management team is disclosed. Operating geography is Denmark only, with no international footprint.
FluimediX firmographics
Firmographics- Name
- FluimediX
- Legal name
- Fluimedix ApS
- Website
- https://fluimedix.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- FluimediX (Point of Cow) is a Danish diagnostics company that sells an on-farm BACT test and Mini-Incubator to dairy farmers for rapid identification of mastitis-causing bacteria, enabling reduced antibiotic use and regulatory compliance.
- Ownership category
- akta.pro rank
FluimediX industry classification
Industry- Product category
- Veterinary Diagnostics
- NAICS
- Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC)
- akta.pro secondary industry
- Milk Quality Testing & Sampling Equipment (SCC, Conductivity, Analyzers) (AFAAAIAD)
Keywords
Where FluimediX is headquartered
LocationHeadquarters
- HQ city
- Taastrup
- HQ country
- Denmark
- HQ region
- Europe
Offices1 record
Markets served
FluimediX business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Hardware Sales: One-time hardware sales including the Mini-Incubator used for processing bacterial tests on-farm.
- BACT Test Consumables: Recurring consumable sales of BACT Gram neg/pos test kits, which are used for each mastitis diagnosis episode.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Starter-Kit BACT Gram neg/pos |
| Unit Pricing | Pay-as-you-go | BACT Gram neg/pos Refill (10 units) |
| Unit Pricing | Pay-as-you-go | Mini-Incubator |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
FluimediX product offering
Product offeringCore offering
FluimediX (under the Point of Cow brand) manufactures and sells the BACT Test, an on-farm visual diagnostic kit that distinguishes Gram-negative from Gram-positive bacteria in bovine mastitis milk samples within roughly 12 hours, paired with the Mini-Incubator hardware that runs the test on the farm. The system is aimed at dairy farmers and veterinarians who need to decide quickly whether a mastitis case requires antibiotic treatment or only pain management, reducing unnecessary antimicrobial use.
Product overview
FluimediX (Point of Cow) offers a portfolio of diagnostic products centered around the BACT on-farm test system for combating mastitis in dairy cattle. The core offering consists of BACT test kits (available as Starter-Kit or 10-stk. refills) that identify Gram-negative versus Gram-positive bacteria in mastitis cases, enabling farmers to avoid unnecessary antibiotic treatments. The Mini-inkubator is an accessory required to process the tests. The product line enables farmers to reduce antibiotic usage by 1/3 to 1/2 of all mastitis cases, with potential annual savings of 30-40,000 DKK for a 200-animal Danish farm.
Differentiator
Problem solved
Functional benefit
Products and services
- BACT Test Starter-Kit Entry-level on-farm diagnostic kit for dairy farmers and on-farm veterinarians to classify bovine mastitis milk samples as Gram-positive or Gram-negative within roughly 12 hours, supporting antibiotic-versus-pain-management decisions.
- BACT Test refill pack Consumable refill pack for the BACT Test system, allowing existing customers to continue running on-farm mastitis bacterial classification assays after the Starter-Kit is consumed.
- Mini-Incubator Proprietary hardware incubator that provides controlled-temperature incubation for BACT Test assays on the dairy farm, enabling the 12-hour Gram-positive/Gram-negative reading without laboratory equipment.
Quantifiable outcome
- Reduces unnecessary antibiotic treatments by 1/3 to half of all mastitis cases
- +2 more outcomes
Companies that use FluimediX
Customer profileSegments2 records
Ideal customer profiles1 record
FluimediX technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
FluimediX partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights3 records
FluimediX competitors and assessment
Company assessmentBroad incumbents
- bioMérieux: Major in vitro diagnostics and industrial microbiology company. Relevant as a bacterial-identification testing franchise owner with adjacent capabilities that could expand into on-farm veterinary applications.
- Elanco Animal Health: Global animal health company with dairy cattle products and an emphasis on responsible antibiotic use. Strategically relevant given FluimediX's antimicrobial stewardship value proposition.
- Thermo Fisher Scientific: Global life sciences leader supplying microbiology culture media, diagnostic reagents, and instruments. Comparable as a high-scale supplier of underlying diagnostic substances and incubation equipment similar to BACT and Mini-Incubator.
- CEVA Santé Animale: Top-five global animal health company with strong European livestock presence, including mastitis and reproductive health products. Relevant as a competing channel partner/acquirer candidate for Danish dairy farms.
- Zoetis: World's largest animal health company, offering diagnostics, vaccines, and pharmaceuticals for livestock including dairy cattle. Overlaps with FluimediX's mastitis/AMR therapeutic area but at multi-billion-dollar scale.
- Eurofins Scientific: World-leading food and agricultural testing laboratory network, including dairy microbiology. Represents the centralized laboratory alternative whose cost structure FluimediX's on-farm model is positioned against.
- Boehringer Ingelheim Animal Health: One of the largest animal health players with a significant bovine/udder-health portfolio. Comparable through mastitis franchise focus and AMR stewardship positioning.
Direct peers
- IDEXX Laboratories: Global leader in veterinary diagnostics, including on-farm and in-clinic tests for livestock. Directly comparable as a veterinary diagnostics products company serving animal health professionals, though at vastly larger scale.
- FOSS Analytical: Danish-headquartered manufacturer of milk composition and quality analyzers (e.g., MilkoScan, BactoScan) used by dairy farmers and processors. Closest geographic and functional analogue for on-farm/in-plant dairy diagnostic instrumentation.
Emerging players
- Enfer Group: Independent veterinary diagnostics laboratory and technology provider focused on animal infectious disease testing. Comparable as a specialized veterinary diagnostics player with similar microbiology testing focus.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
FluimediX social profiles
Digital presenceFluimediX financial estimates
Financial estimateRevenue estimate
Valuation estimate
FluimediX leadership team
Management profileNumber of profiles
Profiles1 record
FluimediX funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FluimediX M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FluimediX
What does FluimediX do?
FluimediX (under the Point of Cow brand) manufactures and sells the BACT Test, an on-farm visual diagnostic kit that distinguishes Gram-negative from Gram-positive bacteria in bovine mastitis milk samples within roughly 12 hours, paired with the Mini-Incubator hardware that runs the test on the farm. The system is aimed at dairy farmers and veterinarians who need to decide quickly whether a mastitis case requires antibiotic treatment or only pain management, reducing unnecessary antimicrobial use.
Is FluimediX a public or private company?
FluimediX is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was FluimediX founded?
FluimediX was founded in 2017. It employs 11 to 50 people.
Where is FluimediX based?
FluimediX is headquartered in Taastrup, Denmark, in the Europe region.
How does FluimediX make money?
Two revenue lines are on record. Diagnostic Hardware Sales are the primary driver. The others are BACT Test Consumables.
Who are FluimediX's main competitors?
Broad incumbents on record are bioMérieux, Elanco Animal Health, Thermo Fisher Scientific, CEVA Santé Animale, Zoetis, Eurofins Scientific and Boehringer Ingelheim Animal Health. Direct peers are IDEXX Laboratories and FOSS Analytical. Enfer Group is listed as an emerging player.
Does FluimediX have an API?
No public API is recorded for FluimediX.
What industry is FluimediX in?
FluimediX's product category is Veterinary Diagnostics. Its primary akta.pro industry code is HLAMADAC, Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology), with a secondary code of AFAAAIAD, Milk Quality Testing & Sampling Equipment (SCC, Conductivity, Analyzers). Its NAICS code is 621511 and its SIC code is 2835.